Search Results - "Mantz, C A"

Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy by Leung, E, Gladwish, A, Sahgal, A, Lo, S S, Kunos, C A, Lanciano, R M, Mantz, C A, Guckenberger, M, Zagar, T M, Mayr, N A, Chang, A R, Jorcano, S, Biswas, T, Pontoriero, A, Albuquerque, K V

“…Stereotactic Ablative Radiotherapy (SABR) is an effective treatment that improves local control for many tumours. However, the role of SABR in gynecological…”
Get full text

Dose-Volume Factors to Select Patient-Specific Image-Guidance Action Thresholds in Prostate Cancer by Block, A. M., Lin, J., Hoggarth, M. A., Quinn, M., Garza, R., Mantz, C. A., Roeske, J. C.

“…For radiation delivery tracking systems that monitor intrafraction prostate motion, generalized departmental threshold protocols may be used. The purpose of…”
Get full text

Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis by Glicksman, R.M., Kishan, A.U., Katz, A.J., Mantz, C.A., Collins, S.P., Fuller, D.B., Steinberg, M.L., Shabsovich, D., Zhang, L., Loblaw, A.

“…There is a lack of early predictive measures of outcome for patients with intermediate-risk prostate cancer (PCa) treated with stereotactic body radiotherapy…”
Get full text

Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer by Mantz, C A, Song, P, Farhangi, E, Nautiyal, J, Awan, A, Ignacio, L, Weichselbaum, R, Vijayakumar, S

“…Impotence is a familiar sequela of definitive external beam radiation therapy (EBRT) for localized prostate cancer; however, nerve-sparing radical…”
Get more information

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer by Mantz, C. A., Vokes, E., Kies, M. S., Mittal, B., Witt, M. E., List, M. A., Weichselbaum, R. R., Haraf, D. J.

“…Summary Purpose: To determine overall survival, progression-free survival, rate of voice preservation, and patterns of failure in locoregionally advanced…”
Get full text

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer by Mantz, C A, Vokes, E E, Stenson, K, Kies, M S, Mittal, B, Witt, M E, List, M A, Weichselbaum, R R, Haraf, D J

“…Locoregionally advanced oropharyngeal cancer has been conventionally treated with either surgery and adjuvant radiotherapy or radiotherapy alone, and clinical…”
Get more information

The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis by Donovan, E., Albuquerque, K.V., Mantz, C.A., Beriwal, S., Keller, A., Chen, H., Lo, S.S., Leung, E.W.

“…The optimal use of stereotactic body radiotherapy (SBRT) for the diverse group of patients with gynecologic malignancies has not been clearly defined. This…”
Get full text

4-Year PSA Response Rate as a Predictive Measure in Intermediate Risk Prostate Cancer Treated With Ablative Therapies: The Sprat Analysis by Glicksman, R., Kishan, A.U., Katz, A.J., Mantz, C.A., Collins, S.P., Fuller, D.B., Steinberg, M.L., Shabsovich, D., Zhang, L., Loblaw, D.A.

“…There is a lack of early predictive measures of outcome for patients with intermediate-risk prostate cancer (PCa) treated with stereotactic body radiotherapy…”
Get full text

Patterns and Predictors of Distant Failure After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Retrospective Multi-Institutional Analysis by Shabsovich, D., Xiang, M., Katz, A.W., Mantz, C.A., Fuller, D.B., van Dams, R., Philipson, R., Juarez, J.E., Ma, T.M., Pepin, A., Suy, S., Stephans, K.L., Murthy, V., Nickols, N.G., Miszczyk, L., Aghdam, N., Glicksman, R., Collins, S.P., Loblaw, D.A., Kishan, A.U.

“…Stereotactic body radiation therapy (SBRT) has emerged as a promising modality for the treatment of prostate cancer (PCa) and involves the delivery of ablative…”
Get full text

Working Towards a New Definition of Biochemical Failure in the Era of Stereotactic Body Radiation Therapy for Prostate Cancer by Ma, T.M., Roy, S., Mantz, C.A., Fuller, D.B., Miszczyk, L., Napieralska, A., Namysł-Kaletka, A.J., Bagshaw, H.P., Buyyounouski, M.K., Glicksman, R., Loblaw, D.A., Katz, A.J., Nickols, N.G., Steinberg, M.L., Philipson, R., Aghdam, N., Suy, S., Pepin, A., Collins, S.P., Kishan, A.U.

“…Since the seminal Phoenix definition (nadir PSA+2) of biochemical failure (BCF) was published in 2006, increasingly more patients with low- and…”
Get full text

Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors by Mantz, C A, Nautiyal, J, Awan, A, Kopnick, M, Ray, P, Kandel, G, Niederberger, C, Ignacio, L, Dawson, E, Fields, R, Weichselbaum, R, Vijayakumar, S

“…Impotence is a familiar sequela of both definitive external-beam radiotherapy (EBRT) and radical prostatectomy for localized prostate cancer. Among surgical…”
Get more information

Advancing Image Guided Visualization of Cellular-based Vaccines, In Vivo, During Combined Radiation/Immunotherapy Protocols by Myslicki, F.A., Mantz, C.A., Finkelstein, S.E.

Get full text

Abstract P5-14-06: Outcomes in 500 patients from a large, retrospective study of APBI with a strut-based breast brachytherapy applicator by Yashar, C, Butler, E, Einck, JP, Finkelstein, SE, Graves, YJ, Han, B, Hong, RL, Komarnicky, LT, Lyden, M, Mahalingam, SB, Mantz, CA, Nasr, N, Nigh, SS, Pollock, J, Reiff, JE, Scanderbeg, D, Snyder, MR, Strasser, JF, Kuske, RR

“…Abstract Purpose/Objectives: The SAVI Collaborative Research Group (SCRG) is a coalition of 14 institutions who have retrospectively compiled a large database…”
Get full text